ATE168009T1 - Hypertone isochlorämische formulierung zur behandlung des kreislaufschocks - Google Patents
Hypertone isochlorämische formulierung zur behandlung des kreislaufschocksInfo
- Publication number
- ATE168009T1 ATE168009T1 AT92917365T AT92917365T ATE168009T1 AT E168009 T1 ATE168009 T1 AT E168009T1 AT 92917365 T AT92917365 T AT 92917365T AT 92917365 T AT92917365 T AT 92917365T AT E168009 T1 ATE168009 T1 AT E168009T1
- Authority
- AT
- Austria
- Prior art keywords
- isochloremic
- hypertone
- formulation
- treatment
- circular shock
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/708,029 US5248507A (en) | 1991-05-31 | 1991-05-31 | Hypertonic isochloremic formulation for circulatory shock |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE168009T1 true ATE168009T1 (de) | 1998-07-15 |
Family
ID=24844101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92917365T ATE168009T1 (de) | 1991-05-31 | 1992-04-27 | Hypertone isochlorämische formulierung zur behandlung des kreislaufschocks |
Country Status (9)
Country | Link |
---|---|
US (2) | US5248507A (de) |
EP (1) | EP0587815B1 (de) |
JP (1) | JPH0714882B2 (de) |
AT (1) | ATE168009T1 (de) |
AU (1) | AU654720B2 (de) |
CA (1) | CA2103246A1 (de) |
DE (1) | DE69226184T2 (de) |
IL (1) | IL101773A (de) |
WO (1) | WO1992021356A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5416078A (en) * | 1990-03-30 | 1995-05-16 | Biomedical Frontiers, Inc. | Fluid resuscitation |
US5248507A (en) * | 1991-05-31 | 1993-09-28 | Board Of Regents, The University Of Texas System | Hypertonic isochloremic formulation for circulatory shock |
US6017953A (en) * | 1993-12-28 | 2000-01-25 | Allergan Sales, Inc. | Thromboxane ligands |
US6566326B1 (en) * | 1996-03-13 | 2003-05-20 | The Regents Of The University Of California | Chemically modified hemoglobin for burn shock resuscitation |
WO1998008500A1 (en) * | 1996-08-26 | 1998-03-05 | Board Of Regents, The University Of Texas System | Hypertonic arginine compositions and methods |
CN1068778C (zh) * | 1998-05-15 | 2001-07-25 | 赵超英 | 救治用的药物组合物及其制备方法 |
GB0011202D0 (en) | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
DE60109184T2 (de) * | 2000-10-16 | 2005-12-29 | Universite De Liege | Medizinische zusammensetzung und insbesondere seine verwendung in der flüssigkeitstherapie |
BRPI0409867A (pt) * | 2003-05-01 | 2006-05-16 | Innogene Kalbiotech Pte Ltd | composição farmacêutica contendo lactato e usos da mesma |
US20050100637A1 (en) * | 2003-11-12 | 2005-05-12 | Robert Murray | Carbohydrate and electrolyte replacement composition |
US20090285909A1 (en) * | 2006-04-03 | 2009-11-19 | Leverve Xavier M | Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof |
WO2007143179A2 (en) | 2006-06-02 | 2007-12-13 | Bengtson Bradley P | Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing |
WO2007142688A1 (en) | 2006-06-02 | 2007-12-13 | Bengtson Bradley P | Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing |
US8551075B2 (en) | 2006-06-02 | 2013-10-08 | Kci Medical Resources | Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing |
CN101164530B (zh) * | 2006-10-18 | 2010-10-20 | 周方强 | 含稳定的丙酮酸钠的水溶液及其制法和用途 |
AU2009293593C1 (en) | 2008-09-18 | 2014-07-10 | Kci Licensing, Inc. | Therapy delivery systems and methods |
CN103877628B (zh) | 2008-10-29 | 2018-04-06 | 凯希特许有限公司 | 减压伤口闭合和处理系统及方法 |
BRPI0914494A2 (pt) | 2008-10-29 | 2015-10-27 | Kci Licensing Inc | conector de cartuchos médicos para conexão liberável a um cartucho médico, método de fabricação de um conector de cartuchos médicos e método de conexão liberável de um cartucho médico |
US8435590B2 (en) * | 2008-11-24 | 2013-05-07 | Stokely-Van Camp, Inc. | Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption |
CA2795977A1 (en) * | 2010-03-12 | 2011-09-15 | Scott Cordray | Method of treatment |
EP2382993A1 (de) | 2010-04-19 | 2011-11-02 | KTB Tumorforschungsgesellschaft mbH | Kombination von Arzneimitteln mit proteinbindenden Prodrugs |
CN103830166B (zh) * | 2012-11-22 | 2015-07-15 | 北京四环制药有限公司 | 一种高渗复苏液的制备方法及其应用 |
US10124021B2 (en) | 2016-12-23 | 2018-11-13 | Andrew L. Gostine | Intravenous fluid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4049795A (en) * | 1971-05-14 | 1977-09-20 | Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie | Treatment of hemorrhagic shock |
US3993750A (en) * | 1974-12-20 | 1976-11-23 | Research Corporation | Aqueous hypertonic solution and compositions useful for preparation of same |
US4908350A (en) * | 1985-10-31 | 1990-03-13 | The Regents Of The University Of California | Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock |
US4927806A (en) * | 1987-04-23 | 1990-05-22 | The Regents Of The University Of California | Saturated salt/concentrated dextran formulation to treat hemorrhage |
US5248507A (en) * | 1991-05-31 | 1993-09-28 | Board Of Regents, The University Of Texas System | Hypertonic isochloremic formulation for circulatory shock |
-
1991
- 1991-05-31 US US07/708,029 patent/US5248507A/en not_active Expired - Fee Related
-
1992
- 1992-04-27 DE DE69226184T patent/DE69226184T2/de not_active Expired - Fee Related
- 1992-04-27 EP EP92917365A patent/EP0587815B1/de not_active Expired - Lifetime
- 1992-04-27 CA CA002103246A patent/CA2103246A1/en not_active Abandoned
- 1992-04-27 AT AT92917365T patent/ATE168009T1/de not_active IP Right Cessation
- 1992-04-27 JP JP4510340A patent/JPH0714882B2/ja not_active Expired - Lifetime
- 1992-04-27 WO PCT/US1992/003489 patent/WO1992021356A1/en active IP Right Grant
- 1992-04-27 AU AU18728/92A patent/AU654720B2/en not_active Ceased
- 1992-05-04 IL IL10177392A patent/IL101773A/en not_active IP Right Cessation
-
1993
- 1993-09-24 US US08/126,242 patent/US5443848A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL101773A (en) | 1996-06-18 |
DE69226184D1 (de) | 1998-08-13 |
EP0587815B1 (de) | 1998-07-08 |
JPH0714882B2 (ja) | 1995-02-22 |
EP0587815A1 (de) | 1994-03-23 |
DE69226184T2 (de) | 1999-04-08 |
WO1992021356A1 (en) | 1992-12-10 |
CA2103246A1 (en) | 1992-12-01 |
AU1872892A (en) | 1993-01-08 |
JPH06500130A (ja) | 1994-01-06 |
US5443848A (en) | 1995-08-22 |
US5248507A (en) | 1993-09-28 |
AU654720B2 (en) | 1994-11-17 |
IL101773A0 (en) | 1992-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE168009T1 (de) | Hypertone isochlorämische formulierung zur behandlung des kreislaufschocks | |
CA2181048A1 (en) | A method for sustained and extended corneal analgesia | |
AR022090A1 (es) | PARTíCULAS PARA LA ADMINISTRACIoN DE UN AGENTE ACTIVO A LOS ALVÉOLOS DE UN PACIENTE HUMANO, UN MÉTODO PARA SU PREPARACIoN, Y EL USO DE LAS MISMAS PARA LA PREPARACIoN DE UN MEDICAMENTO PARA INHALACIoN | |
DE60238825D1 (de) | Behandlung von lungenerkrankungen mit gasförmigem mittel, das zur sättigung von gsno führt | |
ES2185646T3 (es) | Soluciones de aminoacido mejoradas para el tratamiento de pacientes de dialisis peritoneal. | |
US11786561B2 (en) | Approach to sustained production and delivery of nitric oxide and s-nitrosothiols | |
FR2600895B1 (fr) | Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association | |
ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
DE69430813D1 (de) | Verwendung eines inositoltriphosphatesters zur behandlung von entzündungen | |
ATE350024T1 (de) | Flüssige zubereitung enthaltend tobramycin | |
ES2106096T3 (es) | Procedimiento para asegurar glutation intracelular adecuado en el tejido. | |
Platt et al. | Intraperitoneal antiseptics in experimental bacterial peritonitis | |
Rammelkamp et al. | Hemolytic Effect of Tyrothricin. | |
JPS6216409A (ja) | 塩化ナトリウム入り美容剤 | |
JPS57128635A (en) | Pharmaceutical preparation of gamma-globulin for venoclysis | |
MD2354F1 (en) | Method of treatment of the hepatic encephalopathy | |
Jacoby | The toxicity of sulphadiazine and sulphaguanidine to macrophages in vitro | |
RU98101223A (ru) | Способ профилактики и лечения заболеваний полости рта | |
Sachdeva | Ozone Therapy for Periodontal Disease-A Review | |
CA2511749A1 (en) | Surface treatment of sars-infected lung | |
RU94003002A (ru) | Способ пролонгации терапевтического эффекта тимолола | |
Guentherman | The effect of oxygen and oxygenating agents on diseased periodontal tissue | |
JPH0124134B2 (de) | ||
Ackerman et al. | Development of cyclic intermittent hyperbaric oxygenation as a method for prolonging survival during chronic hyperbaric exposure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |